Literature DB >> 12684768

Papillary renal cell carcinoma. Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases.

Yves Allory1, Delphine Ouazana, Eric Boucher, Nicolas Thiounn, Annick Vieillefond.   

Abstract

A series of 43 papillary renal cell carcinomas (PRCCs) were analyzed to investigate the prognostic value of the morphological subtyping (type 1/type 2) proposed by Delahunt and Eble. Twenty-six cases were type 1 (small cuboid cells arranged in single or double layers), 13 cases were type 2 (voluminous eosinophilic cells with irregular pseudostratification pattern), and four cases with oncocytic cells (large eosinophilic cells with round regular nuclei) were distinct from type 2 and grouped apart. All type-1 and oncocytoid-type PRCCs were staged pT1 or pT2, whereas 8/13 type-2 PRCCs were staged pT3 or pT4. Follow-up information (range, 3-113 months; median, 43 months) showed 12 deaths from disease: 2 in the type-1 group,10 in the type-2 group, 0 in the oncocytoid-type group. The Kaplan-Meier analysis showed that pejorative outcome was associated (P<0.001) with high stage (pT3/pT4), high nuclear grade (3/4), morphological type 2, absence of foam cells, and abundant fibrous stroma. The multivariate analysis showed that stage and morphological type were independently associated with survival (P<0.05). These results support the clinical interest of morphological subtyping of PRCCs in the prognosis evaluation of the patients. The four oncocytoid-type PRCCs had a favorable outcome, but additional data are required to evaluate this type of neoplasm.

Entities:  

Mesh:

Year:  2003        PMID: 12684768     DOI: 10.1007/s00428-003-0787-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  28 in total

1.  Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.

Authors:  B Delahunt; J N Eble; M R McCredie; P B Bethwaite; J H Stewart; A M Bilous
Journal:  Hum Pathol       Date:  2001-06       Impact factor: 3.466

2.  Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors.

Authors:  B Delahunt; J N Eble
Journal:  Mod Pathol       Date:  1997-06       Impact factor: 7.842

3.  Papillary renal tumors. Morphologic, cytochemical, and genotypic features.

Authors:  D J Lager; B J Huston; T G Timmerman; S M Bonsib
Journal:  Cancer       Date:  1995-08-15       Impact factor: 6.860

4.  Two new cases of papillary renal cell carcinoma with t(X;1)(p11;q21) in females.

Authors:  C Pérot; J Bougaran; L Boccon-Gibod; S Störkel; G Leverger; J van den Akker; J L Taillemite; J Couturier
Journal:  Cancer Genet Cytogenet       Date:  1999-04

Review 5.  The Heidelberg classification of renal cell tumours.

Authors:  G Kovacs; M Akhtar; B J Beckwith; P Bugert; C S Cooper; B Delahunt; J N Eble; S Fleming; B Ljungberg; L J Medeiros; H Moch; V E Reuter; E Ritz; G Roos; D Schmidt; J R Srigley; S Störkel; E van den Berg; B Zbar
Journal:  J Pathol       Date:  1997-10       Impact factor: 7.996

6.  Papillary renal cell carcinoma: quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy.

Authors:  C L Corless; H Aburatani; J A Fletcher; D E Housman; M B Amin; D S Weinberg
Journal:  Diagn Mol Pathol       Date:  1996-03

7.  Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics.

Authors:  W Thoenes; S Störkel; H J Rumpelt
Journal:  Pathol Res Pract       Date:  1986-05       Impact factor: 3.250

8.  Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma.

Authors:  Melinda E Sanders; Rosemarie Mick; John E Tomaszewski; Frederic G Barr
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

9.  Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes.

Authors:  F Jiang; J Richter; P Schraml; L Bubendorf; T Gasser; G Sauter; M J Mihatsch; H Moch
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

10.  Prognostic significance of morphologic parameters in renal cell carcinoma.

Authors:  S A Fuhrman; L C Lasky; C Limas
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

View more
  15 in total

Review 1.  State of the science: an update on renal cell carcinoma.

Authors:  Eric Jonasch; P Andrew Futreal; Ian J Davis; Sean T Bailey; William Y Kim; James Brugarolas; Amato J Giaccia; Ghada Kurban; Armin Pause; Judith Frydman; Amado J Zurita; Brian I Rini; Pam Sharma; Michael B Atkins; Cheryl L Walker; W Kimryn Rathmell
Journal:  Mol Cancer Res       Date:  2012-05-25       Impact factor: 5.852

2.  Concomitant Heart, Ovaries, and Renal Neoplasms: Atypical Findings During Hypertension Evaluation.

Authors:  Igor Duquesne; Rafael Sanchez-Salas; Konstantinos Zannis; Richard Berry; Lee Nguyen; Eric Barret; Aude Fregeville; Pierre Validire; Xavier Cathelineau
Journal:  Curr Urol Rep       Date:  2016-12       Impact factor: 3.092

3.  Prognostic implications of the magnetic resonance imaging appearance in papillary renal cell carcinoma.

Authors:  Andrew B Rosenkrantz; Aarti Sekhar; Elizabeth M Genega; Jonathan Melamed; James S Babb; Amish D Patel; Andy Lo; Robert M Najarian; Muneeb Ahmed; Ivan Pedrosa
Journal:  Eur Radiol       Date:  2012-08-21       Impact factor: 5.315

4.  Papillary renal cell carcinoma: a clinicopathological and whole-genome exon sequencing study.

Authors:  Kunpeng Liu; Yuan Ren; Lijuan Pang; Yan Qi; Wei Jia; Lin Tao; Zhengyan Hu; Jin Zhao; Haijun Zhang; Li Li; Haifeng Yue; Juan Han; Weihua Liang; Jianming Hu; Hong Zou; Xianglin Yuan; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

5.  Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery.

Authors:  Rodrigo A Ledezma; Edris Negron; Gladell P Paner; Chris Rjepaj; Danny Lascano; Mohammed Haseebuddin; Pankaj Dangle; Arieh L Shalhav; Henry Crist; Jay D Raman; G Joel DeCastro; Lara Harik; Monika Paroder; Robert G Uzzo; Alexander Kutikov; Scott E Eggener
Journal:  World J Urol       Date:  2015-09-25       Impact factor: 4.226

Review 6.  Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer.

Authors:  Theodore F Logan
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

7.  Papillary renal cell carcinoma: clinicopathological characteristics in 40 patients.

Authors:  Takeo Kosaka; Shuji Mikami; Akira Miyajima; Eiji Kikuchi; Ken Nakagawa; Takashi Ohigashi; Jun Nakashima; Mototsugu Oya
Journal:  Clin Exp Nephrol       Date:  2008-03-07       Impact factor: 2.801

8.  Papillary renal cell carcinoma revisited: a comprehensive histomorphologic study with outcome correlations.

Authors:  Joshua I Warrick; Alex Tsodikov; Lakshmi P Kunju; Arul M Chinnaiyan; Ganesh S Palapattu; Todd M Morgan; Ajjai Alva; Scott Tomlins; Angela Wu; Jeffrey S Montgomery; Khaled S Hafez; J Stuart Wolf; Alon Z Weizer; Rohit Mehra
Journal:  Hum Pathol       Date:  2014-02-20       Impact factor: 3.466

9.  Spontaneous rupture of the kidney affected by multifocal papillary renal cell carcinoma.

Authors:  Lucio Dell'Atti
Journal:  Rare Tumors       Date:  2014-12-16

10.  Papillary Renal Cell Carcinoma in Lynch/Muir-Torre Syndrome with Germline Pathogenic Variant in MSH6 and Molecular Analysis: Report of a Case and Review of the Literature.

Authors:  Yu Yang; Shweta Dhar; Jennifer Taylor; Bhuvaneswari Krishnan
Journal:  J Kidney Cancer VHL       Date:  2021-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.